Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Gérard AO"'
Autor:
Destere A; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France.; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Marchello G; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Merino D; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Othman NB; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Lavrut T; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Viard D; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Rocher F; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France., Corneli M; Université Côte d'Azur, Inria, Maison de la Modélisation des Simulations et des Interactions (MSI), MAASAI team, Nice, France., Bouveyron C; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center, Université Côte d'Azur Medical Centre, Nice, France.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2024 May; Vol. 90 (5), pp. 1258-1267. Date of Electronic Publication: 2024 Feb 08.
Autor:
Merino D; Department of Psychiatry, University Hospital of Nice, Nice, France.; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France., Lavrut T; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France., Askenazy F; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval Nice, Nice, France.; CoBTek Laboratory, Université Côte d'Azur, 06000, Nice, France., Thümmler S; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval Nice, Nice, France.; CoBTek Laboratory, Université Côte d'Azur, 06000, Nice, France., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France. pharmacovigilance@chu-nice.fr.
Publikováno v:
European child & adolescent psychiatry [Eur Child Adolesc Psychiatry] 2024 May; Vol. 33 (5), pp. 1383-1393. Date of Electronic Publication: 2023 Jun 12.
Autor:
Merino D; University Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, Nice, France; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital CHU de Nice, Nice, France; Université Côte d'Azur, CoBTeK, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital CHU de Nice, Nice, France; Université Côte d'Azur, Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, Nice, France., Destere A; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital CHU de Nice, Nice, France; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Saidessalam H; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital CHU de Nice, Nice, France., Askenazy F; University Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, Nice, France; Université Côte d'Azur, CoBTeK, Nice, France., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital, Toulouse, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital CHU de Nice, Nice, France., Thümmler S; University Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, Nice, France; Université Côte d'Azur, CoBTeK, Nice, France. Electronic address: susanne.thummler@univ-cotedazur.fr.
Publikováno v:
Psychiatry research [Psychiatry Res] 2024 Apr; Vol. 334, pp. 115786. Date of Electronic Publication: 2024 Feb 14.
Autor:
Destere A; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A.-Dieudonné, Maasai team, 06000 Nice, France., Merino D; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice CHU-Lenval, 06000 Nice, France; Université Côte d'Azur Medical Center, Department of Psychiatry, 06000 Nice, France., Lavrut T; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France., Rocher F; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France., Viard D; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France., Drici MD; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France. Electronic address: pharmacovigilance@chu-nice.fr., Gérard AO; Université Côte d'Azur Medical Center, Department of Clinical Pharmacology, 06000 Nice, France; Université Côte d'Azur Medical Center, Department of Nephrology, 06000 Nice, France; Université Côte d'Azur, CNRS, Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, 06000 Nice, France.
Publikováno v:
Therapie [Therapie] 2024 Mar-Apr; Vol. 79 (2), pp. 161-172. Date of Electronic Publication: 2023 Oct 31.
Autor:
Destere A; Département de Pharmacologie et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, France.; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Teisseyre M; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France.; Département de Néphrologie, Dialyse et Transplantation, CHU de Nice, Université Côte d'Azur, France., Merino D; Département de Pharmacologie et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, France., Cremoni M; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France.; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France., Gérard AO; Département de Pharmacologie et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, France.; Département de Néphrologie, Dialyse et Transplantation, CHU de Nice, Université Côte d'Azur, France., Crepin T; Département de Néphrologie, Dialyse et Transplantation, CHU de Besançon, Besançon, France., Jourde-Chiche N; Département de Néphrologie, Dialyse et Transplantation, Hôpital de la Conception, Assistance Publique-Hôpitaux de Marseille, Marseille, France., Graça D; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France.; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France., Zorzi K; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France., Fernandez C; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France., Brglez V; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France.; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France., Benzaken S; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France., Esnault VLM; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Département de Néphrologie, Dialyse et Transplantation, CHU de Nice, Université Côte d'Azur, France., Benito S; EXACTCURE, Nice, France., Drici MD; Département de Pharmacologie et de Pharmacovigilance, CHU de Nice, Université Côte d'Azur, France., Seitz-Polski B; Centre de Référence Maladies Rares Syndrome Néphrotique Idiopathique, CHU de Nice, Université Côte d'Azur, France.; Unité de Recherche Clinique Côte d'Azur (UR2CA), Université Côte d'Azur, CHU de Nice, France.; Département de Néphrologie, Dialyse et Transplantation, CHU de Nice, Université Côte d'Azur, France.; Laboratoire d'Immunologie, CHU de Nice, Université Côte d'Azur, France.
Publikováno v:
Kidney international reports [Kidney Int Rep] 2023 Nov 03; Vol. 9 (1), pp. 134-144. Date of Electronic Publication: 2023 Nov 03 (Print Publication: 2024).
Autor:
Merino D; Department of Psychiatry, University Hospital of Nice, Nice, France; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France; Université Côte d'Azur Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, Nice, France., Destere A; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France; Université Côte d'Azur, Inria, CNRS, Laboratoire J.A. Dieudonné, Maasai team, Nice, France., Askenazy F; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval Nice, France; CoBTek Laboratory, Université Côte d'Azur, 06000 Nice, France., Dor E; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval Nice, France; CoBTek Laboratory, Université Côte d'Azur, 06000 Nice, France., Benoit M; Department of Psychiatry, University Hospital of Nice, Nice, France., Cherikh F; Department of Addiction, University Hospital of Nice, Nice, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center of Nice, University Hospital Center of Nice, Nice, France. Electronic address: pharmacovigilance@chu-nice.fr.
Publikováno v:
Psychiatry research [Psychiatry Res] 2023 Sep; Vol. 327, pp. 115415. Date of Electronic Publication: 2023 Aug 16.
Autor:
Merino D; Department of Psychiatry, Université Côte d'Azur, University Hospital of Nice, Nice, France.; Department of Pharmacology and Pharmacovigilance Center of Nice, Université Côte d'Azur, University Hospital of Nice, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center of Nice, Université Côte d'Azur, University Hospital of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, Université Côte d'Azur, CNRS, Nice, France., Van Obberghen EK; Department and FHU InovPain, Université Côte d'Azur, University Hospital of Nice, Nice, France., Destere A; Department of Pharmacology and Pharmacovigilance Center of Nice, Université Côte d'Azur, University Hospital of Nice, Nice, France.; Laboratoire J.A. Dieudonné, Université Côte d'Azur, Inria, CNRS, Maasai Team, Nice, France., Lanteri-Minet M; Department and FHU InovPain, Université Côte d'Azur, University Hospital of Nice, Nice, France.; UMR 1107, Migraine and Trigeminal Pain, INSERM, Auvergne University, Clermont-Ferrand, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center of Nice, Université Côte d'Azur, University Hospital of Nice, Nice, France. pharmacovigilance@chu-nice.fr.
Publikováno v:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics [Neurotherapeutics] 2023 Sep; Vol. 20 (5), pp. 1305-1315. Date of Electronic Publication: 2023 Jul 12.
Autor:
Gérard AO; Department of Nephrology-Dialysis-Transplantation, University Hospital Centre of Nice, Nice, France.; Department of Pharmacology and Pharmacovigilance, University Hospital Centre of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, University Côte d'Azur, Nice, France., Merino D; Department of Pharmacology and Pharmacovigilance, University Hospital Centre of Nice, Nice, France., Charbinat A; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, University Côte d'Azur, Nice, France., Fournier J; Department of Nephrology-Dialysis-Transplantation, University Hospital Centre of Nice, Nice, France., Destere A; Department of Pharmacology and Pharmacovigilance, University Hospital Centre of Nice, Nice, France., Loschi M; Department of Hematology, University Hospital Centre of Nice, Nice, France., Cluzeau T; Department of Hematology, University Hospital Centre of Nice, Nice, France., Sicard A; Department of Nephrology-Dialysis-Transplantation, University Hospital Centre of Nice, Nice, France.; Laboratory of Molecular Physio Medicine (LP2M), UMR 7370, CNRS, University Côte d'Azur, Nice, France.; Clinical Research Unit of University Côte d'Azur (UR2CA), University Côte d'Azur, Nice, France., Drici MD; Department of Pharmacology and Pharmacovigilance, University Hospital Centre of Nice, Nice, France. pharmacovigilance@chu-nice.fr.
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2023 Jul; Vol. 37 (4), pp. 521-530. Date of Electronic Publication: 2023 May 11.
Autor:
Destere A; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Merino D; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Bonesso L; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Lavrut T; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Bernasconni A; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Garraffo R; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Gérard AO; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France., Drici MD; Department of Pharmacology and Pharmacovigilance Center, Côte d'Azur University Medical Center, Nice, France. Electronic address: pharmacovigilance@chu-nice.fr.
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences [J Chromatogr B Analyt Technol Biomed Life Sci] 2023 May 01; Vol. 1222, pp. 123694. Date of Electronic Publication: 2023 Mar 31.
Autor:
Merino D; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, 06200 Nice, France.; CoBTek Laboratory, Université Côte d'Azur, 06000 Nice, France.; Pharmacovigilance Center, Department of Pharmacology, University Hospital of Nice, 06000 Nice, France., Gérard AO; Pharmacovigilance Center, Department of Pharmacology, University Hospital of Nice, 06000 Nice, France., Destere A; Pharmacovigilance Center, Department of Pharmacology, University Hospital of Nice, 06000 Nice, France., Askenazy F; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, 06200 Nice, France.; CoBTek Laboratory, Université Côte d'Azur, 06000 Nice, France., Drici MD; Pharmacovigilance Center, Department of Pharmacology, University Hospital of Nice, 06000 Nice, France., Thümmler S; Department of Child and Adolescent Psychiatry, Children's Hospitals of Nice, CHU-Lenval, 06200 Nice, France.; CoBTek Laboratory, Université Côte d'Azur, 06000 Nice, France.
Publikováno v:
Biomedicines [Biomedicines] 2022 Nov 18; Vol. 10 (11). Date of Electronic Publication: 2022 Nov 18.